Journal of Renal Cancer

 ISSN: 2689-8985

Home / Journal of Renal Cancer / Editorial Board / Dr. John P Vasilakos

Editorial board member | Dr. John P Vasilakos


Dr. John P Vasilakos

Senior Researcher
Immunologist & Business Director for TLR Agonists
Woodbury, Minnesota
United States of America
Tel: 651-736-0649

Dr. John P Vasilakos is Senior Researcher Immunologist & Business Director for TLR Agonists in 3M Drug Delivery Systems. Dr. Vasilakos has 19 years experience in the pharmaceutical & biotechnology industry mainly focusing on the use of TLR agonists and beta glucans as vaccine adjuvants and anti-cancer agents. He is an author on over 30 peer-reviewed publications and an inventor on 12 patents. Dr. Vasilakos did his post-doctoral training at Parke-Davis, Ann Arbor, MI. He received his Ph.D. in Molecular Genetics, Biochemistry, and Microbiology from the University of Cincinnati in 1993 and received his BS from Miami University, Oxford OH in 1984. Dr. John P Vasilakos Primary research interests includes pathogen-associated molecular patterns modulationg human innate immunity, specifically on dendritic cells, neutrophils and macrophages.

porn video
porn sex